Axsome Therapeutics, Inc (AXSM) — Analysis Summary
Axsome Therapeutics, Inc (AXSM) has a market cap of $13.04B with year-over-year revenue growth of +65.5%. Net margin stands at -28.7%. The stock trades at a P/E ratio of -69.2.
Key Takeaways
- Revenue changed +65.5% year-over-year
- Net margin of -28.7%
- P/E ratio of -69.2
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, AXSM posted revenue growth of +65.5% and trades at a P/E of -69.2.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.